Juvenile Diabetes Research Foundation-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Juvenile Diabetes Research Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013196
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type one diabetes. The organization conducts clinical trials for curing, preventing and treating for type one diabetes and its complications; and researching new drugs for patients to manage diabetes. It also performs clinical trials and tolerance assay studies in transplantation, autoimmune diseases, and allergy and asthma. JDRF provides diabetes clinical trials to laboratories, educational institutions, and pharmaceutical and medical research companies. The organization has operations in Australia, Canada, Denmark, Israel, Netherlands and the UK. It partners with pharmaceuticals, healthcare and automobile companies to eradicate type one diabetes. JDRF is headquartered in New York, the US.

Juvenile Diabetes Research Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Juvenile Diabetes Research Foundation, Medical Devices Deals, 2011 to YTD 2017 10
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
T1D Innovations Raises US$5 Million In Venture Financing 13
Partnerships 14
Biocon Enters into Agreement with Juvenile Diabetes Research Foundation 14
vTv Therapeutics Enters into Agreement with Juvenile Diabetes Research Foundation 15
JDRF Enters into Agreement with Pacific Diabetes Technologies 16
Diamyd Medical Enter into Partnership with Janssen R&D, JDRF and UAB 17
MannKind Partners with JDRF 18
Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 19
Regimmune Enters into Research Agreement with JDRF and Pfizer 21
Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 22
Juvenile Diabetes Research Partners with Xeris Pharma and LATITUDE Pharma 23
Novo Nordisk Enters Into R&D Agreement With Juvenile Diabetes Research Foundation For Type 1 Diabetes 24
KalVista Pharma Enters Into Research Agreement With JDRF 25
Fast Forward And Juvenile Diabetes Research Foundation Extend Co-Development Agreement With Axxam 26
iCo Therapeutics Enters Into Co-Development Agreement With JDRF For iCo-007 27
Juvenile Diabetes Research Foundation Enters Into Research Collaboration With Selecta Biosciences 28
Juvenile Diabetes Enters Into Co-Development Agreement With Amylin Pharma 29
Equity Offering 30
Bigfoot Biomedical Raises Funds in Equity Financing 30
AnTolRx to Raise USD4 Million in Private Placement of Shares 31
Sernova to Raise USD2.5 Million in Private Placement of Shares 32
Juvenile Diabetes Research Foundation – Key Competitors 33
Juvenile Diabetes Research Foundation – Key Employees 34
Juvenile Diabetes Research Foundation – Locations And Subsidiaries 37
Head Office 37
Recent Developments 38
Corporate Communications 38
Apr 20, 2016: JDRF Announces New International Board of Directors Chairman Mark Fischer-Colbrie 38
Jan 16, 2016: WellCare Gives $5,000 to Juvenile Diabetes Research Foundation to Support Efforts to Find a Cure and New Treatments 39
Government and Public Interest 40
Aug 31, 2017: Role of gut bacteria in averting Type 1 diabetes 40
Aug 01, 2017: Case Western Reserve University: Missing Signals Leads to Diabetic Nerve Injury 42
Mar 20, 2017: New Research Identifies Novel Target for Controlling Immune Response to Implanted Materials 43
Feb 07, 2017: JDRF & Lilly Canada fund UBC research that could allow people with type 1 diabetes to produce their own insulin 44
Jan 12, 2017: JDRF Encouraged by Medicare Decision to Take First Step Toward Coverage of Continuous Glucose Monitors for People with Type 1 Diabetes 45
Oct 12, 2016: JDRF Funds U of T Engineering Research to Improve Cell Transplantation to Treat Type 1 Diabetes 46
Sep 13, 2016: Medtronic Foundation Issues $250,000 in Health Access Grants to Support Local Diabetes Services in Northridge, California 47
Jul 12, 2016: Defymed Receives Support from JDRF to Fight Type 1 Diabetes 48
Jul 07, 2016: Grant funding received to explore Midatech’s gold nanoparticle technology in immunotherapy 49
Jul 07, 2016: Midatech Pharma: Grant funding received to explore Midatech’s gold nanoparticle technology in immunotherapy 50
Product News 51
Jul 14, 2016: JDRF and TrialReach Launch a New, No Cost Clinical Trial Matching Tool to Solve Critical Challenges in Diabetes Research 51
Other Significant Developments 52
Feb 25, 2016: JDRF and Sanofi Announce Expansion of their Joint Research Collaboration to Include Development of Glucose Responsive Insulin Therapies for Treatment of Insulin-Dependent Diabetes 52
Feb 10, 2016: JDRF Announces the Formation of a New Research Advisory Committee to Support Fight Against Type 1 Diabetes 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Key Facts 2
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Juvenile Diabetes Research Foundation, Deals By Therapy Area, 2011 to YTD 2017 9
Juvenile Diabetes Research Foundation, Medical Devices Deals, 2011 to YTD 2017 10
Juvenile Diabetes Research Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
T1D Innovations Raises US$5 Million In Venture Financing 13
Biocon Enters into Agreement with Juvenile Diabetes Research Foundation 14
vTv Therapeutics Enters into Agreement with Juvenile Diabetes Research Foundation 15
JDRF Enters into Agreement with Pacific Diabetes Technologies 16
Diamyd Medical Enter into Partnership with Janssen R&D, JDRF and UAB 17
MannKind Partners with JDRF 18
Sanofi and Juvenile Diabetes Research Foundation Partner with Four Research Organizations 19
Regimmune Enters into Research Agreement with JDRF and Pfizer 21
Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 22
Juvenile Diabetes Research Partners with Xeris Pharma and LATITUDE Pharma 23
Novo Nordisk Enters Into R&D Agreement With Juvenile Diabetes Research Foundation For Type 1 Diabetes 24
KalVista Pharma Enters Into Research Agreement With JDRF 25
Fast Forward And Juvenile Diabetes Research Foundation Extend Co-Development Agreement With Axxam 26
iCo Therapeutics Enters Into Co-Development Agreement With JDRF For iCo-007 27
Juvenile Diabetes Research Foundation Enters Into Research Collaboration With Selecta Biosciences 28
Juvenile Diabetes Enters Into Co-Development Agreement With Amylin Pharma 29
Bigfoot Biomedical Raises Funds in Equity Financing 30
AnTolRx to Raise USD4 Million in Private Placement of Shares 31
Sernova to Raise USD2.5 Million in Private Placement of Shares 32
Juvenile Diabetes Research Foundation, Key Competitors 33
Juvenile Diabetes Research Foundation, Key Employees 34
Juvenile Diabetes Research Foundation, Key Employees (cont..) 36

★海外企業調査レポート[Juvenile Diabetes Research Foundation-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Evotec AG (EVT):医療機器:M&Aディール及び事業提携情報
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • Kinnov Therapeutics SAS-製薬・医療分野:企業M&A・提携分析
    Summary Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company’s pipeline product include KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic receptors …
  • Commonwealth Bank of Australia:企業のM&A・事業提携・投資動向
    Commonwealth Bank of Australia - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Commonwealth Bank of Australia Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Compumedics Ltd (CMP):企業の財務・戦略的SWOT分析
    Summary Compumedics Ltd (Compumedics) is a medical device company that develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems. It provides product categories such as sleep diagnostics, neurology diagnost …
  • Cytokinetics Inc (CYTK):製薬・医療:M&Aディール及び事業提携情報
    Summary Cytokinetics Inc (Cytokinetics) is a late stage biopharmaceutical company, which discovers, develops, and commercializes muscle activators for the treatment of diseases associated with reduced muscle performance. The company’s pipeline encompasses omecamtiv mecarbil, a novel cardiac myosin a …
  • Lloyds Banking Group Plc:戦略・SWOT・企業財務分析
    Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report Summary Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Abercrombie & Fitch Co.:企業の戦略・SWOT・財務情報
    Abercrombie & Fitch Co. - Strategy, SWOT and Corporate Finance Report Summary Abercrombie & Fitch Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Median Technologies SA (ALMDT)-医療機器分野:企業M&A・提携分析
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company provides services such as imaging services for CT, companion and monitoring tests; managed services and investigator site network services. Median’s imaging servic …
  • Manitou Bf Sa:企業の戦略・SWOT・財務分析
    Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report Summary Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Santee Cooper:電力:M&Aディール及び事業提携情報
    Summary Santee Cooper (Santee), formerly South Carolina Public Service Authority, is a state-owned electric and water utility. The company generates the electricity from coal, natural gas, nuclear, hydro, biomass, landfill, and solar sources. It purchases, sells, and exchanges energy with other bulk …
  • Procter & Gamble SA Pty Ltd:企業の戦略的SWOT分析
    Procter & Gamble SA Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • SARomics Biostructures AB:製薬・医療:M&Aディール及び事業提携情報
    Summary SARomics Biostructures AB (Saromics) is a contract research organization that offers structural biology and drug discovery outsourcing services platform for biotech and pharmaceutical companies. The organization provides services in protein crystallization, protein crystallography, protein N …
  • Barkers (Northallerton) Limited:企業の戦略的SWOT分析
    Barkers (Northallerton) Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Nestle SA:企業の戦略・SWOT・財務情報
    Nestle SA - Strategy, SWOT and Corporate Finance Report Summary Nestle SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • AVX Corp (AVX):企業の財務・戦略的SWOT分析
    AVX Corp (AVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Philippine National Bank
    Philippine National Bank - Strategy, SWOT and Corporate Finance Report Summary Philippine National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Hydro-Electric Corporation:電力:M&Aディール及び事業提携情報
    Summary Hydro-Electric Corporation (Hydro Tasmania) is a state owned integrated energy utility. It generates electricity and supplies that on wholesale and retail basis. The company produces power using hydro, gas, wind and solar sources. Hydro Tasmania also retails gas to business and residential c …
  • VeriSign Inc (VRSN):企業の財務・戦略的SWOT分析
    VeriSign Inc (VRSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Hummingbird Diagnostics GmbH:企業の製品パイプライン分析
    Summary Hummingbird Diagnostics GmbH (Hummingbird), is a provider of clinical research and testing services. It develops miRNA-based liquid biopsy diagnostics that find application in early detection of disease indications. The company discovers, validates and analyzes genomic biomarkers especially …
  • Molex LLC-医療機器分野:企業M&A・提携分析
    Summary Molex LLC (Molex), a subsidiary of Koch Industries, is a US-based manufacturer of electronic components. The company principally focuses on manufacturing and sale of electronic, electrical and fiber optic interconnection systems. Molex's product portfolio includes switches, integrated produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆